TFLL Pharma
Life Sciences Incubator Belgium B. Abis B. Abis /
3590 Diepenbeek
BE
TFLL Pharma
Foundation date
21/09/2017
Sector
#PharmaSubsector
- #Pharma - Anti-infectives
- #Pharma - Antibodies
- #Pharma - Biosimilars
- #Pharma - Cell therapy
- #Pharma - Drug delivery
- #Pharma - Gene therapy
- #Pharma - Generics
- #Pharma - Molecular diagnostics
- #Pharma - Nucleic acid drugs
- #Pharma - Peptides
- #Pharma - Proteins
- #Pharma - Small molecule therapeutics
- #Pharma - Stem cells
- #Pharma - Vaccines
Therapeutic areas
TFLL Pharma is a Contract Development Company which develops conventional finished dosage forms and special biotechnological products such as peptides for Pharmaceutical Companies. Expertise Small Molecules Solid dosage forms (Oral) Semi solid dosage and liquid forms (Topical) Parenteral dosage forms (Lyophilized, Liquid and PFS) Liquid dosage forms (Oral suspension and Solution)
Upcoming events
All events-
2809 '22
NLSDays 2022
Event by: SwedenBIO -
2405 '22
PrecisionMed Expo & Summit
Event by: Smart Planet Media International -
2405 '22
EMERGE GHI
Event by: Smart Planet Media International
Latest news
More news-
Latest field trials validate strength of Biotalys’ first biocontrol Evoca
Thursday May 19th 2022
Read more
-
Belgian biotech in European Top-3 despite turbulent times
Wednesday May 18th 2022
Read more
-
KU Leuven announces collaboration and license agreement with Gilead Sciences for the development of new antivirals against the respiratory syncytial virus
Wednesday May 18th 2022
Read more